Multipeutics is the simultaneous application of m ≥ 4 cancer treatments. m = 4 is quadrapeutics, which was invented by researchers at Rice University, Northeastern University, MD Anderson Cancer Centre and China Medical University, see [1] . Multipeutics is our idea. From section 6 Summary, it follows that multipeutics can be more potent than quadrapeutics by comparing these two mathematical models. The first two treatments in quadrapeutics are systemically administered nano gold particles G and lysosomal chemo therapeutic drug D. They form mixed clusters M primarily in cancer cells and can be excited by a laser pulse, the third treatment, to form plasmonic nanobubbles N. These nanobubbles can kill the cancer cells by mechanical impact. If they do not the chemo therapeutic drug can be released into the cytoplasm, which might be lethal to the cancer cell. The fourth treatment is x rays X and the cancer cells have been sensitized to x rays by the treatment. We present an ODE (ordinary differential equations) model of quadrapeutics and of multipeutics, which is quadrapeutics and n ≥ 1 immune or chemo therapies. In the present paper we have found a polynomial p of degree at most 2(n + 3), such that a singular point (C, D, G, M, N, I 1 , ···, I n ) will have p(M) = 0 Here I 1 , ···, I n are immune or chemo therapies. So this gives us candidates for singular points. Quadrapeutics is treated extensively. We find in theorem 3 a polynomium s of degree at most six in M such that a positive singular point (C, D, G, M, N) of the quadrapeutics system will have s(M) = 0. The main theorem of the present paper is the multipeutics theorem, saying that the more treatments we apply the lower the cancer burden, even if we take the doses of each treatment smaller. From the proof of this theorem, we can say, that quadrapeutics can outperform chemo radiation if the nanobubble kill rate k 21 is sufficiently big. See also Figure 1 and Figure 2 and the text explaining them.
Introduction
In [2] we introduced a discrete three dimensional model of cancer growth and a three dimensional ODE model of cancer growth. The variables are C cancer cells, GF growth factors (positive control) and growth inhibitors GI (negative control) in both models. In [3] we showed that there are cancer ODE models with oscillatory behaviour and in [4] we found a discrete mathematical model of C, GF, GI with a nontrivial attractor. In the same paper, we introduced mathematical models of the four phases of adoptive T cell therapy. The first phase is the resection of the tumor and lymphodepletion with a chemo therapeutic drug. The second phase is the pre REP phase where the TILs (tumor infiltrating lymphocytes) from the patients' tumor are expanded with IL-2 treatment. The third phase is the REP phase of expanding and activating the TILs with IL-2 and anti CD3. The fourth phase is the injection of the expanded and activated TIL s back into the patient. We showed that this last phase of the treatment is bistable in the following sense. There is a positive sink and there exist initial conditions such that the cancer burden goes to infinity as , t t + → + where , 0, 0 t t t t
is the domain of definition of the maximal integral curve ( ) c t of the corresponding vector field.
In the present paper, we propose to combine quadrapeutics and immune therapy.
We have written a paper [5] on fundamental concepts in dynamics intended for researchers with a background in medicine.
There are several important monographs related to the present paper, see [6] - [11] . [12] is a mathematical model of miRNAs. [13] [14] [15] are papers on quadrapeutics. [16] [17] are two papers of mine on cancer and mathematics.
The Multipeutics System
Consider the mass action kinetic system
M N → (4) 0 N → (5) 0 M → (6) 0 C X + →
2 C C → (8) 0 C  (9) 0 D  (10) 0 G  (11) 0 1, ,
0 n ∈  ( 0 n = means that the reactions (12) and (13) (10) and (11) give birth and decay rates for cancer cells, chemotherapeutic drug and nano gold particles, respectively. (12) and (13) are immune or chemo therapies. The rate constant in (7) is 27
The ODEs are, see [18] ( ) 
2,10 2 11 2 ,2 2,11 2 1, ,
The corresponding vector field is denoted f. We are going to consider subsystems of (14) to (19) . First of all the chemo radiation system, the vector field in (14) and (15) with the rate constants in (16) to (19) equal to zero and the rest positive. This vector field is denoted
The quadrapeutics system (14) to (18) with the rate constants in (19) equal to zero and the rest positive. This vector field is denoted
Finally the multipeutics systems: the system (14) to (19) with the rate constants in (19) equal to zero, when 1, , i n j n = − +  and the rest positive. This vector field is denoted 5 5 : 
We are going to compare the cancer burden for the different systems. In fact we shall show that there are stable equilibria of the different systems such that
Looking from right to left, this says that the more treatments we apply the lower the cancer burden.
In Figure 1 we have plotted ( ) 
where h is the step size and equal to 0.02. There are 1000 iterations. The numerical analysis indicated, that Figure 1 and Figure 2 . , , 
For instance in f
is an isomorphism, where 11ˆ, b a = 
So there exist
such that
by the implicit function theorem. , , , ,
For q * = we define ( ) 
Finally for the multipeutics system ( ) 1 82 10,2 11,2 11 2 ,2 1, , , , ,
For the chemo radiation model we let
For the quadrapeutics model we let * 0, 1, , . 
Differentiate (48) with respect to t to get 
Differentiate this with respect to t to get
Also differentiate this equation with respect to t to find
From this equation it follows that
Observe that
The third equality holds for ,1, , . q n * =  The fourth equality holds for the multipeutics system
By the fundamental theorem of calculus applied twice
To see the first inequality, observe that there exists a positive constant c, such 
Finally differentiate (57) to (60) with respect to t to get
However when
To see this differentiate (17) twice with respect to t to find
If we now differentiate (18) twice with respect to t we find
which is what we sought to show.
and 2 2 
we have
when 0 t = and hence also for small 0. t >
The fundamental theorem of calculus applied three times gives 
0 0 Consider also the system (1) to (13) 
We are now going to find candidates of the positive singular points of the different systems. We start with f and assume that all ij k are positive. (19) gives 
Insert these formulas in (14) 
We can isolate C in this equation to find 
We now get by multiplying with the product of the denominators in (104), 
( ) 2,10 2 11 2 ,2 2,10 2 2,11 2 1 1, 
If we now insert the formulas for , G C and multiply with 
and assume that it is negative. Then
is the same for all treatments. But now the first coordinate of formula (48) 
and when 2,10 2 2,11 2 11 2 ,2 0, 1, , .
We can now take 21 k big and argue as in theorem 1. □
The Chemo Radiation Model
Consider the mass action kinetic system 
This system with 0 δ = is similar to the reduced system from [17] .
GF C
where we have added the last reaction. The complexes are ( ) , ,
We can assume that GF is at equilibrium 
The reduced system is then ,
We shall find the singular points of the chemo radiation system. 
and ( ) 
hence this is a stable, positive singular point.
Consider the chemo radiation system where 10,2 98
and all other 1. 
where we have used that
It is a simple matter to check that the first and last of these are stable equilibria and the middle is an unstable saddle by computing the trace and determinant of the linearization of q f in the singular points. I have plotted a phase portrait for these values of the parameters in Figure 3. 
The Quadrapeutics Equilibrium Equation
We shall find the quadrapeutics equilibrium equation too. Proof. Isolate D, G, M, N from (15), (16), (17), (18) , ,
where we have multiplied with
We shall now insert 1  21  65  23  54  2,10 , ,
and this is ( ) , ,
and this is ( ) 3  82  21  26  23  54  2,10 , , 
The last two ds give ( ) 
and they are both singular points (numerical evidence). We have used, that 
The Extended Quadrapeutics Model
This is the system (1) to (11) and the reactions 
The vector field is denoted q g . Denote by cr g the vector field in (260), (261) and (262) with the rate constants in (263), (264) and (265) all equal to zero and the rest positive. 21  23  98  28  27  2,14 13,12  2,13  54  2,10  2,11  65  25  26 13,10 , , , , ,
And for cr * = ( ) , , , 
Use the implicit function theorem to find a mapping 
Summary
Consider the extended quadrapeutics system and the additional reactions 
